0
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma. (nejm.org)
Authors:
Choueiri TK
… Powles TB
Journal:
New England Journal of Medicine
Published:
2026-07-02
DOI:
https://doi.org/10.1056/NEJMoa2518245
Comments
Login to comment.
No comments yet. Be the first!